Shares of RH RH rose sharply in the pre-market trading after the company released quarterly results.
RH posted downbeat earnings and sales results for its third quarter. However, the company raised revenue guidance across the board based on current trends. The company expects fourth-quarter demand growth of 20% to 22%, and fourth-quarter revenue growth of 18% to 20%, according to data from Benzinga Pro.
RH shares jumped 17.1% to $446.44 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Pearl Holdings Acquisition Corp PRLH gained 44.1% to $17.50 in pre-market trading after adding 4% on Thursday.
- Loop Industries, Inc. LOOP gained 41.3% to $1.74 in pre-market trading. Loop Industries completed convertible preferred financing with Reed Societe Generale Group.
- SPI Energy Co., Ltd.. SPI gained 39.5% to $0.4884 in pre-market trading after climbing around 14% on Thursday.
- TruGolf Holdings, Inc. TRUG gained 30.5% to $0.6785 in pre-market trading after jumping around 18% on Thursday.
- Gaxos.ai Inc. GXAI rose 18.6% to $4.39 in pre-market trading after falling 27% on Thursday.
- Lichen China Limited LICN gained 16% to $0.2272 in pre-market trading after dipping more than 25% on Thursday. Lichen China announced a $2.70 million registered direct offering.
- Broadcom Inc. AVGO gained 14.8% to $207.50 in pre-market trading as the company posted better-than-expected earnings for its fourth quarter. The company said it sees first-quarter revenue of approximately $14.6 billion, versus the $14.612 billion estimate. The company also issued adjusted EBITDA guidance of approximately 66 percent of projected revenue for the first quarter.
- EVgo, Inc. EVGO climbed 13.2% to $7.04 in pre-market trading. EVgo closed its $1.25 billion guaranteed loan facility from U.S. Department of Energy.
- Lytus Technologies Holdings PTV. Ltd. LYT gained 12.4% to $1.27 in pre-market trading after falling around 10% on Thursday.
Losers
- Repare Therapeutics Inc. RPTX shares tumbled 35.8% to $2.55 in pre-market trading after the company reported results of Lunresertib and Camonsertib combination from MYTHIC Phase 1 gynecologic expansion clinical trial.
- Nuburu, Inc. BURU declined 32.1% to $0.34 in pre-market trading after jumping 102% on Thursday.
- Candel Therapeutics, Inc. CADL shares fell 30.9% to $6.77 in pre-market trading after the company announced the pricing of public offering.
- Inovio Pharmaceuticals, Inc. INO fell 22.8% to $2.90 in pre-market trading after the company announced a proposed public offering.
- Comstock Holding Companies, Inc. CHCI dipped 17.8% to $7.00 in pre-market trading after declining 4% on Thursday.
- Actuate Therapeutics, Inc. ACTU shares fell 15.5% to $7.00 in pre-market trading.
- Northfield Bancorp, Inc. NFBK fell 14.8% to $11.00 in pre-market trading.
- SEALSQ Corp LAES shares dipped 13% to $1.61 in pre-market trading. SEALSQ announced the pricing of $10 million registered direct offering.
- Pliant Therapeutics, Inc. PLRX fell 9.8% to $12.50 in today's pre-market trading.
- Kimball Electronics, Inc. KE fell 4.5% to $18.32 in pre-market trading.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.